Dimensional Fund Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $52M | Sell |
637,704
-253,011
| -28% | -$18.3M | 0.01% | 1583 |
|
|
2026
Q1 | $60.7M | Buy |
890,715
+263,623
| +42% | +$18.7M | 0.01% | 1400 |
|
|
2025
Q4 | $47.6M | Sell |
627,092
-146,086
| -19% | -$10.6M | 0.01% | 1535 |
|
|
2025
Q3 | $47.4M | Buy |
773,178
+245,774
| +47% | +$12.8M | 0.01% | 1544 |
|
|
2025
Q2 | $25.8M | Sell |
527,404
-34,435
| -6% | -$1.63M | 0.01% | 1850 |
|
|
2025
Q1 | $28.6M | Buy |
561,839
+456,789
| +435% | +$22.8M | 0.01% | 1772 |
|
|
2024
Q4 | $4.74M | Buy |
+105,050
| New | +$4.5M | ﹤0.01% | 2547 |
|
|
2023
Q3 | – | Sell |
-15,851
| Closed | -$645K | – | 3500 |
|
|
2023
Q2 | $645K | Buy |
15,851
+535
| +3% | +$26.2K | ﹤0.01% | 3011 |
|
|
2023
Q1 | $742K | Buy |
+15,316
| New | +$700K | ﹤0.01% | 2961 |
|
|
2022
Q3 | $783K | Buy |
+15,593
| New | +$764K | ﹤0.01% | 2947 |
|
|
2021
Q3 | – | Sell |
-64,228
| Closed | -$2.71M | – | 3526 |
|
|
2021
Q2 | $2.71M | Sell |
64,228
-2,581
| -4% | -$111K | ﹤0.01% | 2795 |
|
|
2021
Q1 | $3.16M | Sell |
66,809
-10,585
| -14% | -$629K | ﹤0.01% | 2725 |
|
|
2020
Q4 | $4.72M | Sell |
77,394
-2,862
| -4% | -$169K | ﹤0.01% | 2551 |
|
|
2020
Q3 | $3.75M | Buy |
80,256
+3,923
| +5% | +$193K | ﹤0.01% | 2546 |
|
|
2020
Q2 | $3.87M | Sell |
76,333
-12,970
| -15% | -$637K | ﹤0.01% | 2569 |
|
|
2020
Q1 | $3.98M | Buy |
89,303
+54,778
| +159% | +$2.76M | ﹤0.01% | 2497 |
|
|
2019
Q4 | $1.66M | Sell |
34,525
-57,987
| -63% | -$2.46M | ﹤0.01% | 2902 |
|
|
2019
Q3 | $3.13M | Sell |
92,512
-87,797
| -49% | -$3.82M | ﹤0.01% | 2743 |
|
|
2019
Q2 | $8.11M | Sell |
180,309
-32,617
| -15% | -$1.29M | ﹤0.01% | 2467 |
|
|
2019
Q1 | $8.02M | Sell |
212,926
-30,926
| -13% | -$1.04M | ﹤0.01% | 2481 |
|
|
2018
Q4 | $8.37M | Buy |
243,852
+28,969
| +13% | +$1.04M | ﹤0.01% | 2420 |
|
|
2018
Q3 | $10.1M | Hold |
214,883
| – | – | ﹤0.01% | 2435 |
|
|
2018
Q2 | $7.25M | Sell |
214,883
-3,730
| -2% | -$116K | ﹤0.01% | 2544 |
|
|
2018
Q1 | $5.92M | Sell |
218,613
-302,779
| -58% | -$7.67M | ﹤0.01% | 2570 |
|
|
2017
Q4 | $8.7M | Sell |
521,392
-3,718
| -0.7% | -$62.9K | ﹤0.01% | 2429 |
|
|
2017
Q3 | $10.5M | Sell |
525,110
-3,476
| -0.7% | -$68.1K | ﹤0.01% | 2356 |
|
|
2017
Q2 | $9.69M | Buy |
528,586
+5,960
| +1% | +$80.3K | ﹤0.01% | 2369 |
|
|
2017
Q1 | $5.14M | Buy |
522,626
+210,166
| +67% | +$2.54M | ﹤0.01% | 2555 |
|
|
2016
Q4 | $3.41M | Sell |
312,460
-958
| -0.3% | -$10.1K | ﹤0.01% | 2660 |
|
|
2016
Q3 | $4.39M | Buy |
313,418
+212,635
| +211% | +$1.73M | ﹤0.01% | 2559 |
|
|
2016
Q2 | $707K | Buy |
+100,783
| New | +$739K | ﹤0.01% | 2992 |
|
Other funds holding PTCT
RI
JT
Dimensional Fund Advisors's PTCT Position: Q2 2026 in Review
Dimensional Fund Advisors reduced its PTC Therapeutics (PTCT) stake by 28% in Q2 2026, selling an estimated $18.3M and leaving 637,704 shares worth $52M. The position accounts for 0.01% of the portfolio, ranked #1583.
Dimensional Fund Advisors first reported a position in PTCT in Q2 2016 and has held it in 31 quarters since. The position peaked at $60.7M in Q1 2026. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Dimensional Fund Advisors held 637,704 shares of PTC Therapeutics worth $52M as of Q2 2026.
- Dimensional Fund Advisors sold 253,011 PTC Therapeutics shares in Q2 2026, an estimated $18.3M.
- PTC Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1583 holding.
- Dimensional Fund Advisors first reported a position in PTC Therapeutics in Q2 2016 and has held it in 31 quarters since.
- Dimensional Fund Advisors's PTC Therapeutics position peaked at $60.7M in Q1 2026.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.